The expression of activating receptor gene of natural killer cells (KLRC3)‎ in patients with type 1diabetes mellitus (T1DM)‎

Abstract EN

Objectives : To identify the possible role of natural killer (NK) cells in the pathogenesis of type 1 diabetes mellitus (T1DM ) through studying the expression of the KLRC3 gene, which encodes the NK cell activating receptor (NKG2E).

Methods: This study was conducted at Alexandria University Children’s Hospital from April to October 2015.

The study was conducted with 30 newly diagnosed T1DM patients (15 males and 15 females), aged 7–13 years (10.6±1.8 years) and 20 non-diabetic subjects served as age- and sex-matched controls.

The patients were further sub-divided into two groups; group I included patients who first presented with classical symptoms of DM (polyuria, polydipsia, and polyphagia) without diabetes ketoacidosis (DKA) and group II included patients who first presented with DKA.

The expression of the KLRC3 gene was measured in each group using the real-time polymerase chain reaction.

Results: KLRC3 gene expression was significantly downregulated in T1DM cases compared to healthy controls (p = 0.001).

Expression was more downregulated in group I patients (p = 0.008).

Moreover, there was higher mean value of glycated heamoglobin and lower C-peptide levels in group I than group II.

Serum pancreatic amylase showed no significant difference between the two groups.

Conclusions: KLRC3 gene expression was downregulated in patients with T1DM compared to healthy controls.

Downregulation of expression was greater in DKA patients compared to those who presented with classical symptoms.

Expression of KLRC3 in T1DM might play a role in the pathogenesis of T1DM and could be a predictor of its severity.